Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan

Blood (2022) 140 (Supplement 1): 6421–6423.

https://doi.org/10.1182/blood-2022-157702

Published: 2022

Journal Articles

Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)

Blood (2022) 140 (Supplement 1): 11890–11892.

https://doi.org/10.1182/blood-2022-164977

Published: 2022

Journal Articles

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Blood (2021) 138 (Supplement 1): 2451.

https://doi.org/10.1182/blood-2021-146340

Published: 2021

Journal Articles

Utx Insufficiency Cooperates with Braf V600E in the Induction of Myeloma in Mice

Ola Rizq, MD PhD, Naoya Mimura, MD PhD, Motohiko Oshima, PhD, Shuji Momose, MD PhD, Yaeko Nakajima-Takagi, PhD, Kazumasa Aoyama, PhD, Atsunori Saraya, Tohru Iseki, MD PhD, Emiko Sakaida, MD PhD, Chiaki Nakaseko, MDPhD, Yutaka Okuno, MD, PhD, Hiroaki Honda, MD PhD, Jun-ichi Tamaru, MDPhD, Atsushi Iwama, MD PhD

Blood (2018) 132 (Supplement 1): 1005.

https://doi.org/10.1182/blood-2018-99-114053

Published: 2018

Journal Articles

The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders

Michihide Tokuhira, Yuta Kimura, MD, Yuka Tanaka, MD, Yasuyuki Takahashi, MD PhD, Tatsuki Tomikawa, MD PhD, Junichi Watanabe, MD PhD, Tomoe Anan-Nemoto, MD PhD, Morihiko Sagawa, MD PhD, Shuji Momose, MD PhD, Morihiro Higashi, MD PhD, Tabayashi Takayuki, MD PhD, Reiko Nakaseko, MD PhD, Jun-ichi Tamaru, MDPhD, Masahiro Kizaki, MDPhD

Blood (2018) 132 (Supplement 1): 1589.

https://doi.org/10.1182/blood-2018-99-114382

Published: 2018

Journal Articles

Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders

Michihide Tokuhira, MD, Shuntaro Saito, MD, Ayumi Okuyama, MD, Katsuya Suzuki, MD, Morihiro Higashi, MD, Shuju Momose, MD, Takayuki Shimizu, MD, Takehiko Mori, MD PhD, Tomoe Anan-Nemoto, MD, Koichi Amano, MD, Shinichiro Okamoto, MD PhD, Tsutomu Takeuchi, MD, Jun-ichi Tamaru, MDPhD, Masahiro Kizaki, MDPhD

Blood (2017) 130 (Supplement 1): 4024.

https://doi.org/10.1182/blood.V130.Suppl_1.4024.4024

Published: 2017

Journal Articles

Clinicopathological Study of Methotrexate-Associated Lymphoproliferative Disorders in Rheumatoid Arthritis Patients: Histological Classification and Predictive Factors for Disease Progression

Daisuke Kurita, MD, Hiroaki Miyoshi, MDPhD, Ayako Ichikawa, MDPhD, Yuya Sasaki, MD, Keisuke Kawamoto, MDPhD, Joji Shimono, MD, Masao Matsuoka, MDPhD, Masahiro Kizaki, MDPhD, Masao Seto, MD PhD, Jun-ichi Tamaru, MDPhD, Michihide Tokuhira, MD, Koichi Ohshima, MDPhD

Blood (2017) 130 (Supplement 1): 4168.

https://doi.org/10.1182/blood.V130.Suppl_1.4168.4168

Published: 2017

Journal Articles

CD14-CD15+, Possible Cells Are Potent Myeloid-Derived Suppressor Cells, Which Affect the Pathogenesis of Induction and Regression in Methotrexate-Mediated Lymphoproliferative Disorders

Michihide Tokuhira, MD PhD, Shuntaro Saito, MD, Yuka Tanaka, MD, Yasuyuki Takahashi, MD, Yuta Kimura, MD, Tatsuki Tomikawa, MD, Tomoe Anan, MD, PhD, Shuji Momose, MD PhD, Morihiro Higashi, MD, PhD, Takayuki Shimizu, MD PhD, Takehiko Mori, MD PhD, Takayuki Tabayashi, MD PhD, Reiko Watanabe, MD PhD, Jun-ichi Tamaru, MD, PhD, Shinichiro Okamoto, MD PhD, Masahiro Kizaki, MD PhD

Blood (2016) 128 (22): 2946.

https://doi.org/10.1182/blood.V128.22.2946.2946

Published: 2016

Journal Articles

Clinicopathological Features and Prognosis of B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma with t(14;18) and 8q24 Translocation in the Rituximab Era

Nozomi Niitsu, MD, PhD, Naoki Takahashi, Mika Kohri, Norio Asou, MD PhD, Jun-ichi Tamaru, Jun Sakai, Shigeo Nakamura, Ikuo Miura, Masataka Okamoto

Blood (2014) 124 (21): 1633.

https://doi.org/10.1182/blood.V124.21.1633.1633

Published: 2014

Journal Articles

Serum Soluble LR11 Can Predict High FLIPI-2 Score in Follicular Lymphoma.

Takeharu Kawaguchi, MD, Chikako Ohwada, MD, PhD, Naomi Shimizu, MD, PhD, Masahiro Takeuchi, MD, PhD, Emiko Sakaida, M.D., PhD., Yusuke Takeda, M.D., PhD., Shio Sakai, MD, PhD, Shokichi Tsukamoto, MD, Atsuko Yamazaki, MD, Morihiro Higashi, M.D., PhD., Jun-Ichi Tamaru, M.D., PhD., Kotaro Yokote, M.D., PhD., Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD

Blood (2012) 120 (21): 2673.

https://doi.org/10.1182/blood.V120.21.2673.2673

Published: 2012

Journal Articles

LR11 Is a Potential Serum and Histological Biomarker for Intravascular Large B-Cell Lymphoma

Chikako Ohwada, MD, PhD, Takeharu Kawaguchi, MD, Naomi Shimizu, MD, PhD, Masahiro Takeuchi, MD, PhD, Emiko Sakaida, M.D., PhD., Yusuke Takeda, M.D., PhD., Kazuhisa Fujikawa, MD, PhD, Kosei Matsue, MD, PhD, Morihiro Higashi, M.D., PhD., Jun-Ichi Tamaru, M.D., PhD., Kotaro Yokote, M.D., PhD., Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD

Blood (2012) 120 (21): 5104.

https://doi.org/10.1182/blood.V120.21.5104.5104

Published: 2012

Journal Articles

Serum Soluble LR11 As a Novel Biomarker for B Cell Lymphoma

Takeharu Kawaguchi, M.D., Chikako Ohwada, MD, PhD., Morihiro Higashi, M.D., PhD., Masahiro Takeuchi, MD, PhD, Shio Sakai, M.D., PhD., Yusuke Takeda, M.D., PhD., Naomi Shimizu, MD, PhD, Emiko Sakaida, M.D., PhD., Kohei Takubo, PhD., Hiroyuki Ebinuma, PhD., Isamu Fukamachi, PhD., Jun-Ichi Tamaru, M.D., PhD., Koutaro Yokote, MD, PhD, Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD

Blood (2011) 118 (21): 1581.

https://doi.org/10.1182/blood.V118.21.1581.1581

Published: 2011

Journal Articles

Multicenter Phase II Study of the CyclOBEAP Regimen for Patients with Peripheral T-Cell Lymphoma with Analysis of Biomakers.

Nozomi Niitsu, MD, PhD, Miyuki Hayama, MD, PhD, Yuki Hagiwara, Ken Tanae, Mika Kohri, Naoki Takahashi, Shigeo Nakamura, MD, Jun-ichi Tamaru, Masataka Okamoto, MD, PhD

Blood (2010) 116 (21): 2795.

https://doi.org/10.1182/blood.V116.21.2795.2795

Published: 2010

Journal Articles

Cytotoxic Molecule (CM)-Positive Classical Hodgkin Lymphoma: a Clinicopathologic Study in Comparison with Nodal Peripheral T-Cell Lymphoma of Not Otherwise Specified Type Possessing CM Expression.

Naoko Asano, MD, PhD, Jun-Ichi Tamaru, MD, PhD, Fumihiro Ishida, MD, PhD, Tadashi Yoshino, MD, PhD, Yoshitoyo Kagami, MD, PhD, Yasuo Morishima, MD, PhD, Masao Seto, MD, PhD, Tomohiro Kinoshita, MD, PhD, Shigeo Nakamura, MD, PhD

Blood (2009) 114 (22): 1549.

https://doi.org/10.1182/blood.V114.22.1549.1549

Published: 2009

Journal Articles

Age-related Epstein-Barr virus (EBV)–associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients

Naoko Asano, Kazuhito Yamamoto, Jun-Ichi Tamaru, Takashi Oyama, Fumihiro Ishida, Koichi Ohshima, Tadashi Yoshino, Naoya Nakamura, Shigeo Mori, Osamu Yoshie, Yoshie Shimoyama, Yasuo Morishima, Tomohiro Kinoshita, Shigeo Nakamura

Blood (2009) 113 (12): 2629–2636.

https://doi.org/10.1182/blood-2008-06-164806

Published: 2009

Includes: Supplemental data

Journal Articles

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders: Comparison with EBV-Positive Classical Hodgkin Lymphoma in Elderly Patients

Naoko Asano, MD, Kazuhito Yamamoto, MD, Jun-Ichi Tamaru, MD, Takashi Oyama, MD, Fumihiro Ishida, MD, Koichi Ohshima, MD, Tadashi Yoshino, MD, Naoya Nakamura, MD, Shigeo Mori, MD, Osamu Yoshie, MD, Yoshie Shimoyama, MD, Yasuo Morishima, Tomohiro Kinoshita, MD, Shigeo Nakamura, MD

Blood (2008) 112 (11): 5282.

https://doi.org/10.1182/blood.V112.11.5282.5282

Published: 2008

Journal Articles

Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5

Takuhei Murase, Motoko Yamaguchi, Ritsuro Suzuki, Masataka Okamoto, Yumiko Sato, Jun-ichi Tamaru, Masaru Kojima, Ikuo Miura, Naoyoshi Mori, Tadashi Yoshino, Shigeo Nakamura

Blood (2006) 109 (2): 478–485.

https://doi.org/10.1182/blood-2006-01-021253

Published: 2006

Journal Articles

Phase I/II Study of the Rituximab-EPOCT Regimen in Combination with G-CSF in Patients with Relapsed or Refractory Follicular Lymphoma Including Evaluation of Its Cardiotoxicity Using B-Type Natriuretic Peptide and Troponin T Levels.

Nozomi Niitsu, M.D., Mika Khori, M.D., Miyuki Hayama, Masaaki Higashihara, M.D., Jun-ichi Tamaru, M.D.

Blood (2004) 104 (11): 4608.

https://doi.org/10.1182/blood.V104.11.4608.4608

Published: 2004

Journal Articles

High Incidence of Asian Variant Intravascular Large B-Cell Lymphoma (IVL) among IVL in Japan: Clinicopathologic Study of 95 Patients.

Takuhei Murase, M.D., Ritsuro Suzuki, M.D., Motoko Yamaguchi, M.D., Masataka Okamoto, M.D., Yumiko Sato, M.D., Jun-ichi Tamaru, M.D., Naoyoshi Mori, M.D., Tadashi Yoshino, M.D., Shigeo Nakamura, M.D.

Blood (2004) 104 (11): 1365.

https://doi.org/10.1182/blood.V104.11.1365.1365

Published: 2004

Journal Articles

De novo CD5 + diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients

Motoko Yamaguchi, Masao Seto, Masataka Okamoto, Ryo Ichinohasama, Naoya Nakamura, Tadashi Yoshino, Junji Suzumiya, Takuhei Murase, Ikuo Miura, Takashi Akasaka, Jun-ichi Tamaru, Ritsuro Suzuki, Yoshitoyo Kagami, Masami Hirano, Yasuo Morishima, Ryuzo Ueda, Hiroshi Shiku, Shigeo Nakamura

Blood (2002) 99 (3): 815–821.

https://doi.org/10.1182/blood.V99.3.815

Published: 2002

NARROW

Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan

Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Utx Insufficiency Cooperates with Braf V600E in the Induction of Myeloma in Mice

The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders

Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders

Clinicopathological Study of Methotrexate-Associated Lymphoproliferative Disorders in Rheumatoid Arthritis Patients: Histological Classification and Predictive Factors for Disease Progression

CD14-CD15+, Possible Cells Are Potent Myeloid-Derived Suppressor Cells, Which Affect the Pathogenesis of Induction and Regression in Methotrexate-Mediated Lymphoproliferative Disorders

Clinicopathological Features and Prognosis of B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma with t(14;18) and 8q24 Translocation in the Rituximab Era

Serum Soluble LR11 Can Predict High FLIPI-2 Score in Follicular Lymphoma.

LR11 Is a Potential Serum and Histological Biomarker for Intravascular Large B-Cell Lymphoma

Serum Soluble LR11 As a Novel Biomarker for B Cell Lymphoma

Multicenter Phase II Study of the CyclOBEAP Regimen for Patients with Peripheral T-Cell Lymphoma with Analysis of Biomakers.

Cytotoxic Molecule (CM)-Positive Classical Hodgkin Lymphoma: a Clinicopathologic Study in Comparison with Nodal Peripheral T-Cell Lymphoma of Not Otherwise Specified Type Possessing CM Expression.

Age-related Epstein-Barr virus (EBV)–associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders: Comparison with EBV-Positive Classical Hodgkin Lymphoma in Elderly Patients

Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5

Phase I/II Study of the Rituximab-EPOCT Regimen in Combination with G-CSF in Patients with Relapsed or Refractory Follicular Lymphoma Including Evaluation of Its Cardiotoxicity Using B-Type Natriuretic Peptide and Troponin T Levels.

High Incidence of Asian Variant Intravascular Large B-Cell Lymphoma (IVL) among IVL in Japan: Clinicopathologic Study of 95 Patients.

De novo CD5 + diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only